How does one assess early rheumatoid arthritis in daily clinical practice?

van Riel, 1994, Clinical assessment and clinical trials in rheumatoid arthritis, Current Opinion in Rheumatology, 6, 132, 10.1097/00002281-199403000-00003 van Riel, 1992, Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis, British Journal of Rheumatology, 31, 793, 10.1093/rheumatology/31.12.793 Felson, 1993, The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials, Arthritis and Rheumatism, 36, 729, 10.1002/art.1780360601 Furst, 1989, Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis, Journal of Rheumatology, 16, 313 van Riel, 1995, Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis, British Journal of Rheumatology, 34, 40, 10.1093/rheumatology/XXXIV.suppl_4.40 Mladenovic, 1995, Safety and effectiveness of leflunomide in the treatment of patients with rheumatoid arthritis, Arthritis and Rheumatism, 38, 1595, 10.1002/art.1780381111 Elliot, 1994, Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis, Lancet, 344, 1105, 10.1016/S0140-6736(94)90628-9 Moreland, 1997, Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein, New England Journal of Medicine, 337, 141, 10.1056/NEJM199707173370301 Sherrer, 1986, The development of disability in rheumatoid arthritis, Arthritis and Rheumatism, 29, 494, 10.1002/art.1780290406 Van Zeben, 1993, Factors predicting outcome of rheumatoid arthritis: results of a followup study, Journal of Rheumatology, 22, 4 Harrison, 1996, Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation, Journal of Rheumatology, 23, 1326 Fleming, 1993, Prognostic values of early features in rheumatoid disease, British Journal of Rheumatology, 32, 717 Corbett, 1993, Factors predicting death, survival, and functional status in a prospective study of rheumatoid disease over fifteen years of disease, British Journal of Rheumatology, 10.1093/rheumatology/32.8.717 Wolfe, 1991, The assessment and prediction of functional disability in rheumatoid arthritis, Journal of Rheumatology, 18, 1299 van der Heijde, 1992, Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective followup study of 147 patients, British Journal of Rheumatology, 31, 519, 10.1093/rheumatology/31.8.519 Eberhardt, 1990, Early rheumatoid arthritis onset, course and outcome over 2 years, Rheumatology International, 10, 135, 10.1007/BF02274837 Graudal, 2000, Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate and hemoglobin. Long term course and association to radiographic progression, Journal of Rheumatology, 27, 47 Mottonen, T, T, Prediction of erosiveness and rates of development of new erosions in early rheumatoid arthritis Gough, 1994, Genetic typing of patients with inflammatory arthritis at presentation is predictive of outcome, Arthritis and Rheumatism, 37, 1166, 10.1002/art.1780370809 Weyand, 1992, The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis, Annals of Internal Medicine, 117, 801, 10.7326/0003-4819-117-10-801 Weyand, 1992, Homozygosity for the HLA-DRB1 allele selects for extra-articular manifestation in rheumatoid arthritis, Journal of Clinical Investigation, 89, 2033, 10.1172/JCI115814 Silman, 1986, HLA-DR4 as a predictor of outcome three years after onset of rheumatoid arthritis, Rheumatology International, 6, 233, 10.1007/BF00541373 Paimela, 1993, The prognostic value of HLA-DR4 and B27 antigens in early rheumatoid arthritis, Scandinavian Journal of Rheumatology, 22, 220, 10.3109/03009749309095126 Kroot, 2000, The prognostic value of the antiperinuclear factor, determined by a recently developed peptide-based ELISA, using anti citrulline-containing peptide antibodies (anti-CCP) in patients with recent-onset rheumatoid arthritis, Arthritis and Rheumatism, 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6 O'Dell, 1998, HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments, Annals of the Rheumatic Diseases, 57, 209, 10.1136/ard.57.4.209 Van Zeben, 1993, Factors predicting outcome of rheumatoid arthritis: results of a followup study, Journal of Rheumatology, 20, 1288 Woolf, 1991, Predictors of the longterm outcome of early synovitis: a five year follow-up study, British Journal of Rheumatology, 30, 251, 10.1093/rheumatology/30.4.251 Eberhardt, 1993, HLA-DR antigens, GM allotypes, and anti-allotypes in early rheumatoid arthritis—their relation to disease progression, Journal of Rheumatology, 10, 71 Mustila, 2000, Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis, Arthritis and Rheumatism, 43, 1371, 10.1002/1529-0131(200006)43:6<1371::AID-ANR22>3.0.CO;2-R Hayem, 1999, Anti SA antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis, Journal of Rheumatology, 26, 7 Klimiuk, 1997, Tissue cytokine patterns distinguish variants of rheumatoid synovitis, American Journal of Pathology, 151, 1311 Pando, 1995, Prevalence of chlamydia trachomatis by PCR in the synovium of patients with early rheumatoid arthritis, Arthritis and Rheumatism, 38, S287 Hochberg, 1999, Early aggressive DMARD therapy. The key to slowing disease progression in early rheumatoid arthritis, Scandinavian Journal of Rheumatology, 28, 3, 10.1080/030097499750042227 Levin, 1996, Clinical assessment of the 1987 ACR criteria for rheumatoid arthritis, Scandinavian Journal of Rheumatology, 25, 277, 10.3109/03009749609104058 van Leeuwen, 1994, Interrelationship of outcome measures and process variables in early rheumatoid arthritis, Journal of Rheumatology, 21, 425 Baecklund, 1998, Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study, British Medical Journal, 317, 180, 10.1136/bmj.317.7152.180 Rasker, 1981, Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis, Annals of the Rheumatic Diseases, 40, 115, 10.1136/ard.40.2.115 van de Putte, 1997, Currently used second-line agents: do they control the disease course?, Clinical and Experimental Rheumatology, 15, 71 van der Heijde, 1990, Judging disease activity in clinical practice in rheumatoid arthritis. First step in the development of a ‘disease activity score’, Annals of the Rheumatic Diseases, 49, 916, 10.1136/ard.49.11.916 Prevoo, 1995, Modified disease activity scores that include twenty-eight-joint counts, Arthritis and Rheumatism, 38, 44, 10.1002/art.1780380107 van der Heijde, 1993, Validity of single variables and indices to measure disease activity in rheumatoid arthritis, Journal of Rheumatology, 20, 538 Fuchs, 1993, The use of the disease activity score in the analysis of clinical trials in rheumatoid arthritis, Journal of Rheumatology, 20, 1863 Felson, 1995, American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis, Arthritis and Rheumatism, 38, 727, 10.1002/art.1780380602 van Gestel, 1996, Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis, Arthritis and Rheumatism, 39, 34, 10.1002/art.1780390105 van Gestel, 1998, Validation of rheumatoid arthritis improvement criteria that include simplified joint counts, Arthritis and Rheumatism, 41, 1845, 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K van Gestel, 1999, ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials, Journal of Rheumatology, 26, 705 Pincus, 1999, ACR20: clinical or statistical significance?, Arthritis and Rheumatism, 42, 1572, 10.1002/1529-0131(199908)42:8<1572::AID-ANR2>3.0.CO;2-G Felson, 1998, Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?, Arthritis and Rheumatism, 41, 1564, 10.1002/1529-0131(199809)41:9<1564::AID-ART6>3.0.CO;2-M Schiff, 1999, Comparison of ACR response, Numeric ACR, and ACR AUC as measures of clinical improvement in RA clinical trials, Arthritis and Rheumatism, 42, S81 Finck, 1999, A phase III trial of etanercept vs methotrexate (MTX) in early rheumatoid arthritis (Enbrel ERA trial), Arthritis and Rheumatism, 42, S117 Fuchs, 1989, A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis, Arthritis and Rheumatism, 32, 531, 10.1002/anr.1780320504 Prevoo, 1993, Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis, British Journal of Rheumatology, 32, 589, 10.1093/rheumatology/32.7.589 Smolen, 1995, Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity, Arthritis and Rheumatism, 38, 38, 10.1002/art.1780380106 Mason, 1992, The rapid assessment of disease activity in rheumatology (RADAR) questionnaire, Arthritis and Rheumatism, 35, 156, 10.1002/art.1780350206 Hanly, 1996, Self-assessment of disease activity by patients with rheumatoid arthritis, Journal of Rheumatology, 23, 1531 Prevoo, 1996, Validity and reproducibility of self-administered joint counts. A large prospective longitudinal followup study in patients with rheumatoid arthritis, Journal of Rheumatology, 23, 841 Stucki, 1995, A self administered Rheumatoid Arthritis Disease Activity Index (RADAI) for epidemiological research: psychometric properties and correlation with parameters of disease activity, Arthritis and Rheumatism, 38, 795, 10.1002/art.1780380612 Pinals, 1981, Preliminary criteria for remission in rheumatoid arthritis, Arthritis and Rheumatism, 24, 1308, 10.1002/art.1780241012 Prevoo, 1996, Remission in a prospective study of patients with rheumatoid arthritis. ARA preliminary remission criteria in relation to the disease activity score, British Journal of Rheumatology, 35, 1101, 10.1093/rheumatology/35.11.1101 Fransen, 2000, Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index, Rheumatology, 39, 321, 10.1093/rheumatology/39.3.321 Geborek, 2000, Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis, Rheumatology, 39, 1159, 10.1093/rheumatology/39.10.1159